Boryung Biopharma

Bio & Pharma Boryung, Lotus Pharma signs CDMO deal on anticancer injection

South Korea's Boryung Corp. said on Thursday it signed a contract with Lotus Pharmaceutical, a Taiwanese oncology firm, for contract development and...

Bio & Pharma GC Biopharma acquires ABO Holding for $96 mn

South Korea’s GC Biopharma Corp. said on Thursday it acquired the US-based medical-grade source blood plasma company ABO Holding Inc. The...

Aerospace & Defense Boryung invests $10 million in Intuitive Machines

South Korea's Boryung Corp. said on Friday it bought $10.0 million in shares of US-based lunar lander company Intuitive Machines to expand its space...

Bio & Pharma Samsung Biologics wins $668 million CDMO deal with European pharma

Samsung Biologics Co., the world’s largest contract drugmaker, said on Wednesday it has signed two drug manufacturing contracts worth a combin...

Bio & Pharma GC Biopharma sells HK subsidiary to CR Pharm Group for $254 mn

South Korea’s GC Biopharma Corp. announced on Wednesday that it signed a share purchase agreement (SPA) to sell all its shares in its Hong Kon...

Bio & Pharma GC Biopharma exports Alyglo to US

South Korea’s major pharmaceutical company GC Biopharma Corp. announced on Monday that it shipped the initial volume of Alygro, its immunoglob...

Mergers & Acquisitions Eugene PE, KDB PE to acquire Boryung Biopharma for $231 million

A consortium of Eugene Private Equity and Korea Development Bank Private Equity will acquire 80% of South Korean vaccine maker Boryung Biopharma Co....

Bio & Pharma OCI eyes acquisition of US biopharmaceutical company

OCI Holdings Co., South Korea’s largest polysilicon maker, is looking abroad to acquire a biopharmaceutical company in the US in a consortium,...

Bio & Pharma Korea’s Celltrion, SK Biopharmaceuticals benefit from direct US sales

Celltrion Inc. and SK Biopharmaceuticals Co. are witnessing improving sales revenue and profitability by selling their products through their own ma...

Bio & Pharma Drug maker Boryung targets its highest-ever sales in 2024

Boryung Corp., formerly Boryung Pharmaceutical Co., aims to join the 1 trillion won ($748 million) sales club this year, driven by new chronic disea...

Bio & Pharma GC Biopharma aims to boost Alyglo sales sixfold in the US

CHEONGJU, North Chungcheong Province -- South Korea’s major pharmaceutical company GC Biopharma Corp. aims to raise the sales of Alyglo, its i...

Bio & Pharma Biopharma M&As: Next big thing for South Korean manufacturers

When Orion Corp., known for its signature snack cake Choco-Pie, announced a $415 million deal to acquire biotech startup LegoChem Biosciences Inc. l...

Aerospace & Defense Boryung, Axiom Space launch joint venture in Korea

Boryung Corp., a South Korean healthcare investment company, said on Thursday it has officially launched a joint venture with Axiom Space, a US comm...

Bio & Pharma Boryung, HK inno.N to co-market Kanarb, K-CAB

South Korea’s pharmaceutical companies Boryung Corp. and HK inno.N announced on Wednesday that they will start co-marketing for their respec...

Bio & Pharma GC Biopharma gets FDA approval for Alyglo

South Korea’s GC Biopharma Corp. announced on Monday that it received approval from the US Food and Drug Administration (FDA) for the immuno...

Bio & Pharma GC Biopharma breaks ground on blood product plant in Indonesia

South Korea’s GC Biopharma Corp. broke ground on Wednesday on Indonesia’s first blood product plant through technology transfer.Indonesi...

Bio & Pharma Hanwha to re-enter biopharma market, targeting biomaterials

South Korea’s Hanwha Group will re-enter the biopharmaceutical market to become the country’s sole producer of tris buffers, a key reage...

Bio & Pharma GC Biopharma wins $10 mn order for flu vaccine in Thailand

South Korea's GC Biopharma Corp. announced on Thursday that its flu vaccine GC Flu secured a $10 million order in the upcoming bid by Thailand's Gov...

Bio & Pharma SK Biopharma’s Cenobamate US patent extended by 2032

South Korea's SK Biopharmaceuticals announced on Friday an extension of its US patent for the epilepsy treatment Cenobamate, now set to expire on Oc...

Bio & Pharma S.Korea's Boryung gets gov’t OK for diabetes drug Trubuddy

South Korea’s Boryung Corp. on Tuesday said it received approval from the Ministry of Food and Drug Safety for its new compound diabetes drug ...

Bio & Pharma EuBiologics, GC Biopharma to jointly produce cholera vaccine

South Korea's EuBiologics Co., the world's leading cholera vaccine company, has signed a joint production agreement with GC Biopharma Corp. to produ...

Bio & Pharma Boryung Pharma's sales surpass $311 mn in H1 2023

South Korea’s Boryung Corp. has alleviated the fear of falling behind in its sector expressed by its third-generation chairman Jay Kim Jung-Gy...

Bio & Pharma GC Biopharma wins approval for quadrivalent flu vaccine in Egypt

South Korea's GC Biopharma Corp. announced on Wednesday that its quadrivalent influenza vaccine "GC Flu Quadrivalent" has received approval from Egy...

Bio & Pharma Prestige Biopharma participates in US gov’t Cancer Moonshot

Prestige Biopharma, a Singapore-based biopharmaceutical company with operations in South Korea and the US, announced on Tuesday that it will partici...

Bio & Pharma GC Biopharma inks $90mn deal for blood products in Brazil

South Korea's GC Biopharma Corp. on Monday announced on Monday that it has a supply contract with Blau Farmacêutica, a Brazilian pharmaceutica...

Bio & Pharma GC Biopharma wins contract to build blood products plant in Indonesia

GC Biopharma Corp., a South Korean pharmaceutical company, announced on Thursday that it has received approval from the Indonesian Ministry of Healt...

Bio & Pharma CrystalGenomics to sell largest 20% stake to Invites Healthcare for $44 mn

CrystalGenomics Inc., South Korea’s first-generation biopharma venture company, will sell new shares worth 58 billion won ($44 million) in a b...

Bio & Pharma Merck to build biopharma raw material plant in Korea

Global pharmaceutical company Merck is considering a plan to establish a biopharmaceutical raw material production facility in Daejeon.South Korean ...

Mergers & Acquisitions Dongwon backs out of Boryung Biopharma buyout deal

Dongwon Industries Co., South Korea’s No. 1 canned tuna producer, has backed out of a deal estimated between $400 million and $500 million to ...

Bio & Pharma Boryung, Axiom Space to set up JV to explore space healthcare options

South Korea's Boryung Corp., just decades ago a mom-and-pop pharmacy, will bring its healthcare expertise to space with Axiom Space Inc., a US comme...